| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-07 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-07 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.34 | 2e-06 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.33 | 3e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |